Group 1: Tencent's Financial Performance - Tencent's international gaming revenue increased by 23% year-on-year to 16.6 billion yuan in Q1 2025, marking a record high for three consecutive quarters, driven by strong performances from PUBG MOBILE and Supercell games [1] - Domestic gaming revenue reached 42.9 billion yuan, a 24% year-on-year increase, attributed to revenue growth from Honor of Kings and Peacekeeper Elite, along with contributions from newly released games [1] Group 2: WeChat's E-commerce Initiatives - Tencent announced the establishment of an e-commerce product department to explore new transaction models within WeChat, aiming to accelerate the development of transaction infrastructure and ecosystem [2] Group 3: GlaxoSmithKline's Acquisition - GlaxoSmithKline has agreed to acquire Boston Pharmaceuticals' subsidiary BP Asset IX for up to $2 billion to gain rights to Efimosfermin, a drug in Phase III clinical trials for treating fatty liver disease, with an upfront payment of $1.2 billion and potential milestone payments of up to $800 million [3] Group 4: Investment and Financing Activities - Carl Power completed nearly 300 million yuan in financing to advance the commercialization of L4 autonomous freight delivery, with operations expanding across seven cities and 20 clients [4] - Zhejiang Junliang Supply Chain Technology Service Co., Ltd. secured 10 million yuan in angel round financing to enhance its digital risk control system and supply chain financial services platform [6]
氪星晚报|微信成立电商产品部,探索微信内交易新模式;万兴科技将携四款AI成果亮相GITEX欧洲展;全国人大常委会2025年度立法工作计划公布